Effects of axonal injury on ganglion cell survival and glutamate homeostasis

Brain Research Bulletin

Volumn 62, Issue 6, 2004, Pages 485-490

  Vorwerk, Christian K ^a,c   Zurakowski, David ^b   McDermott, Luann M ^a   Mawrin, Christian ^c   Dreyer, Evan B ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d Glaucoma Cataract Consultants   (United States)

Author keywords

Axotomy; Excitotoxicity; Optic nerve crush; Retinal ganglion cells

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MEMANTINE; NIMODIPINE; RILUZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AXONAL INJURY; BRAIN NERVE CELL; CELL DEATH; CELL LOSS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DOSE REGIMEN; HOMEOSTASIS; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; PRIORITY JOURNAL; RAT; RETINA GANGLION CELL; STEADY STATE;

EID: 1342291352     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00075-3     Document Type: Conference Paper

References (29)

1. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14:1994;4368-4374.
2. Bleakman D., Roback J.D., Wainer B.H., Miller R.J., Harrison N.L. Calcium homeostasis in rat septal neurons in tissue culture. Brain Res. Bull. 600:1993;257-267.
3. Chen H.S.V., Pelligrini J.W., Aggarwal S.K., Lei S.Z., Warach S., Jensen F.E., Lipton S.A. Open channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J. Neurosci. 12:1992;4427-4436.
4. Chen H.S., Wang Y.F., Rayudu P.V., Edgecomb P., Neill J.C., Segal M.M., Lipton S.A., Jensen F.E. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience. 86:1998;1121-1132.
5. S.A. Cohen, M. Meys, T.L. Tarvin, The Pico-Tag Method: A Manual of Advanced Techniques for Amino Acid Analysis, Millipore Corporation, Bedford, 1989, pp. 2-57.
6. N.R. Draper, H. Smith, Applied Regression Analysis, 3rd ed., Wiley, New York, 1998, pp. 505-528.
7. Fisher M., Grotta J. New uses for calcium channel blockers. Therapeutic implications. Drugs. 46:1993;961-975.
8. Gietzen D.W., Leung P.M.B., Rogers Q.R. Norepinephrine and amino acids in prepyriform cortex of rats fed imbalanced amino acid diets. Physiol. Behav. 36:1986;1071-1080.
9. Grafstein B. The nerve cell body response to axotomy. Exp. Neurol. 48:1975;32-51.
10. Grosskreutz C.L., Katowitz W.R., Freeman E.E., Dreyer E.B. Lidocaine toxicity to rat retinal ganglion cells. Curr. Eye Res. 18:1999;363-367.
11. Hubert J.P., Delumeau J.C., Glowinski J., Premont J., Doble A. Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br. J. Pharmacol. 113:1994;261-267.
12. Ikonomidou C., Turski L. Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit. Rev. Neurobiol. 10:1996;239-263.
13. Lagreze W.A., Knorle R., Bach M., Feuerstein T.J. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest. Ophthalmol. Vis. Sci. 39:1998;1063-1066.
14. Lipton S. Prospects for clinically tolerated NMDA antagonists. Trends Neurosci. 16:1993;527-532.
15. Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. Am. Med. Assoc. Arch. Ophthalmol. 58:1957;193-201.
16. Malgouris C., Daniel M., Doble A. Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci. Lett. 177:1994;95-99.
17. Mosinger J.L., Price M.T., Bai H.Y., Xiao H., Wozniak D.F., Olney J.W. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp. Neurol. 113:1991;10-17.
18. Olney J.W. Glutamate-induced retinal degeneration in neonatal mice: electron microscopy of the acutely evolving lesion. J. Neuropathol. Exp. Neurol. 28:1969;455-474.
19. Otori Y., Wei J.Y., Barnstable C.J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 39:1998;972-981.
20. Sautter J., Sabel B.A. Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. Eur. J. Neurosci. 5:1993;680-690.
21. Shapiro S.S., Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika. 52:1965;591-611.
22. Simon P.D., Vorwerk C.K., Mansukani S.S., Chen S.J., Wilson J.M., Zurakowski D., Bennett J., Dreyer E.B. Bcl-2 gene therapy exacerbates excitotoxicity. Hum. Gene Ther. 10:1999;1715-1720.
23. R.R. Sokal, F.J. Rohlf, Biometry, 3rd ed., Freeman, New York, 1995, pp. 486-496.
24. Vorwerk C.K., Lipton S.A., Zurakowski D., Hyman B.T., Sabel B.A., Dreyer E.B. Chronic low dose glutamate is toxic to retinal ganglion cells toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37:1996;1618-1624.
25. Vorwerk C.K., Simon P., Gorla M., Katowitz W., Zurakowski D., Levin L.A., Dreyer E.B. Pilocarpine is toxic to retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 40:1999;813-816.
26. Yoles E., Muller S., Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J. Neurotrauma. 14:1997;665-675.
27. Yoles E., Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 153:1998;1-7.
28. Yoles E., Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch. Ophthalmol. 116:1998;906-910.
29. Yoles E., Wheeler L.A., Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest. Ophthalmol. Vis. Sci. 40:1999;65-73.